NCT00411164View on ClinicalTrials.gov

A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis

PHASE3CompletedINTERVENTIONAL

Enrollment

990

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

May 31, 2005

Conditions

Osteoarthritis, HipOsteoarthritis, Knee

Interventions

DRUG

OROS hydromorphone HCI (slow release)

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY

NCT00411164 - A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis | Biotech Hunter | Biotech Hunter